ArticleWorld journal of gastroenterology2017
Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.
Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Evaluation of a Registered Nurse-Led Outpatient Paracentesis Service for Decompensated Cirrhosis: A Retrospective Review.Journal of evaluation in clinical practice · 2026Article
- Readmission rates among patients with cirrhosis across different follow-up periods and prevalence of major complications: a systematic review and meta-analysis.Open medicine (Warsaw, Poland) · 2026Article
- Article
- A Qualitative Study on Cryptogenic Hepatic Encephalopathy Screening Cognition Among Hepatology Medical Care Personnel.Journal of multidisciplinary healthcare · 2025Article
- Evaluation of a nurse practitioner-led post-discharge transitional care program for patients with liver disease: A retrospective cohort study.Canadian liver journal · 2024Article
- Risk factors for hospital readmission among patients with cirrhosis and ascites in China: a retrospective observational study.The Journal of international medical research · 2024Observational
- Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023Article
- Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.International journal of molecular sciences · 2023Review
- Neutrophil-to-lymphocyte ratio predicts 30-, 90-, and 180-day readmissions of patients with hepatic encephalopathy.Frontiers in medicine · 2023Article
- Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis.Medicina (Kaunas, Lithuania) · 2022Article
- Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.World journal of gastroenterology · 2022Review
- Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022Review
- Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.Digestive diseases and sciences · 2022Review
- Nationwide analysis of incidence and predictors of 30-day readmissions in patients with decompensated cirrhosis.Frontline gastroenterology · 2022Article
- Identifying and mitigating factors contributing to 30-day hospital readmission in high risk patient populations.Annals of translational medicine · 2021Article
- Hepatic Encephalopathy: From Metabolic to Neurodegenerative.Neurochemical research · 2021Review
- Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database.Annals of translational medicine · 2021Article
- A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study.JMIR medical informatics · 2020Article
- Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.Gastroenterology report · 2020Article
- Risk Factors for Liver Cirrhosis-Related Readmissions in the Largest Ethnic Minority in United States.Gastroenterology research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo reduce readmissions and improve patient outcomes in cirrhotic patients through better understanding of readmission predictors.
methodsWe performed a single-center retrospective study of patients admitted with decompensated cirrhosis from January 1, 2011 to December 31, 2013 (
resultsOne hundred thirty-two patients (59.4%) were readmitted at least once during the study period. Median time to first and second readmissions were 54 and 93 d, respectively. Thirty and 90-d readmission rates were 20.7 and 30.1 percent, respectively. Predictors of 30-d readmission included education level, hepatic encephalopathy at index, ALT more than upper normal limit and Medicare coverage. There were no statistically significant differences in readmission rates when stratified by discharge disposition, outpatient follow-up provider or time to first outpatient visit.
conclusionReadmissions are challenging aspect of care for cirrhotic patients and risk continues beyond 30 d. More initiatives are needed to develop enhanced, longitudinal post-discharge systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.